U.S. R&D Blueprint Calls Out China’s New Parity
A newly released White House science policy document warns that China has reached parity with the United States in research and development spending when measured on a purchasing‑power‑adjusted basis. The report, titled “Science: A New Golden Age,” was issued by the Office of Science and Technology Policy and serves as a strategic plan for overhauling America’s $200 billion annual federal R&D apparatus.
Over the last twenty years, China’s investment in research has escalated to a point where its PPP‑adjusted outlays equal those of the United States. The analysis presents a chart that juxtaposes the United States, China, and the European Union’s 27 member nations, highlighting that the United States now faces a “purchasing‑power‑parity (PPP) adjusted” equal competitor for the first time.
Beijing has placed scientific research at the core of its broader competitive strategy, centralizing decision‑making and aligning funding across multiple sectors. This comprehensive, society‑wide model has allowed China to marshal resources for fundamental science, accelerate development in strategically important technologies, and streamline its innovation pipeline.
The report also draws attention to China’s push toward autonomous laboratories—AI‑driven facilities capable of designing, executing, and analyzing experiments with limited human input. While U.S. national laboratories have begun experimenting with prototype autonomous setups, the paper notes that Canada, China and other nations are moving ahead more rapidly.
The White House blueprint recommends concentrating federal resources on eight priority domains: artificial intelligence, quantum computing, semiconductors, nuclear fission and fusion, advanced communications, robotics, manufacturing, and space systems. India or Indian research bodies are not mentioned, nor are they identified as prospective partners in any of the national technology missions cited.
In a parallel FY 2028 memorandum, federal agencies are authorized to pursue funding models that involve “international partners” sharing costs, yet the document does not specify any particular country or research arena for such collaboration.
Other nations are referenced as examples of reform. The United Kingdom is credited for reorganizing its science‑funding system and establishing a “meta‑science unit” in 2024 to test new funding approaches and verify peer‑review integrity. Norway’s portfolio‑based research council is highlighted as a system that allocates money based on a long‑term national research agenda.
Historical context is provided, recalling how Japanese manufacturers once dominated the global memory‑chip market, which led to the creation of a U.S. semiconductor consortium in 1987 backed by federal funds. The report cautions that many U.S. scientific breakthroughs have yielded industrial advantages to foreign firms, noting that the only manufacturer of extreme‑ultraviolet lithography machines is headquartered in Europe and that Asian companies command the lithium‑ion battery supply chain.
In conclusion, the White House argues that the arrival of a true R&D peer and the ascendancy of artificial intelligence demand a fresh, structural re‑organization of America’s research enterprise.